PLoS ONE · 2011 · 45 citations · 32 references
Life SciencesBiochemistryMolecular BiologyEnzymologyMolecular NeuroscienceNeurodegenerationMolecular Basis Of NeurodegenerationNeurodegenerative DiseasesNeurodegenerative DisordersParkinson DiseaseProtein DegradationE2 Ubiquitin-conjugating EnzymesIntrinsic ActivityParkin MutationsProtein DeubiquitinationProtein Mass SpectrometryRegulation By E3 Ubiquitin LigasesUbiquitin BindingUbiquitin System
BACKGROUND: Mutations in the parkin gene, which encodes a ubiquitin ligase (E3), are a major cause of autosomal recessive parkinsonism. Although parkin-mediated ubiquitination was initially linked to protein degradation, accumulating evidence suggests that the enzyme is capable of catalyzing multiple forms of ubiquitin modifications including monoubiquitination, K48- and K63-linked polyubiquitination. In this study, we sought to understand how a single enzyme could exhibit such multifunctional catalytic properties. METHODS AND FINDINGS: By means of in vitro ubiquitination assays coupled with mass spectrometry analysis, we were surprised to find that parkin is apparently capable of mediating E2-independent protein ubiquitination in vitro, an unprecedented activity exhibited by an E3 member. Interestingly, whereas full length parkin catalyzes solely monoubiquitination regardless of the presence or absence of E2, a truncated parkin mutant containing only the catalytic moiety supports both E2-independent and E2-dependent assembly of ubiquitin chains. CONCLUSIONS: Our results here suggest a complex regulation of parkin's activity and may help to explain how a single enzyme like parkin could mediate diverse forms of ubiquitination.
32
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1
Sven Geisler, Kira M. Holmström, Diana Skujat et al. · Nature Cell Biology · 2010 · 2.8K citations
A proteomics approach to understanding protein ubiquitination
Junmin Peng, Daniel Schwartz, Joshua E. Elias et al. · Nature Biotechnology · 2003 · 1.6K citations